Drug intelligence / Profile preview

Evamitra

Development stage
Unknown
Lead developer
Navil Laboratories
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Evamitra is an Ayurvedic proprietary medicine formulated as an oral syrup, developed and manufactured by Navil Laboratories. It is designed to support women's reproductive health from menarche to menopause, specifically targeting hormonal disturbances, menstrual bleeding disorders, painful menstruation (dysmenorrhea), and premenstrual syndrome (PMS). The formulation is a multi-herb mixture containing traditional Ayurvedic ingredients such as Ashoka, Lodhra, Shatavari, Gokhru, Dashmool, Kantakari, Anantamul, Nirgundi, Nagarmoth, Dhataki pushpa, Manjishtha, Guduchi, Punarnava, Triphala, Kumari, Shilajit, Ashwagandha, Shankhpushpi, Brahmi, Mandur, and Ulatkambal. These components work synergistically to regulate menstrual cycles, reduce hormonal fluctuations, alleviate uterine muscle spasms, and provide anti-inflammatory and uterine-tonic benefits.

Brand names
EvamitraEvamitra Forte
Other names
Evamitra Forte SyrupEvamitra Syrup

Beyond the preview

Go deeper on Evamitra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evamitra.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call